#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Lipid oxidation is one of the major causes of food deterioration , leading to the loss of nutrients and bioactives , off flavors development , and could also form potentially toxic compounds .
3-1	17-22	Lipid	person|abstract[4]	new|new[4]	coref|coref|coref|coref	4-20|4-20[20_4]|4-20|4-20[20_4]
3-2	23-32	oxidation	abstract[4]	new[4]	_	_
3-3	33-35	is	_	_	_	_
3-4	36-39	one	abstract[5]	new[5]	_	_
3-5	40-42	of	abstract[5]	new[5]	_	_
3-6	43-46	the	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-7	47-52	major	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-8	53-59	causes	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-9	60-62	of	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-10	63-67	food	abstract[5]|abstract[6]|substance|abstract[8]	new[5]|new[6]|new|new[8]	coref|coref	10-20|10-20
3-11	68-81	deterioration	abstract[5]|abstract[6]|abstract[8]	new[5]|new[6]|new[8]	_	_
3-12	82-83	,	_	_	_	_
3-13	84-91	leading	_	_	_	_
3-14	92-94	to	_	_	_	_
3-15	95-98	the	abstract[9]	new[9]	_	_
3-16	99-103	loss	abstract[9]	new[9]	_	_
3-17	104-106	of	abstract[9]	new[9]	_	_
3-18	107-116	nutrients	abstract[9]|substance	new[9]|new	_	_
3-19	117-120	and	abstract[9]	new[9]	_	_
3-20	121-131	bioactives	abstract[9]|substance[11]	new[9]|new[11]	_	_
3-21	132-133	,	abstract[9]|substance[11]	new[9]|new[11]	_	_
3-22	134-137	off	abstract[9]|substance[11]	new[9]|new[11]	_	_
3-23	138-145	flavors	abstract[9]|substance[11]|abstract|abstract[13]	new[9]|new[11]|new|new[13]	coref|coref	8-23[57_0]|8-23[57_0]
3-24	146-157	development	abstract[9]|substance[11]|abstract[13]	new[9]|new[11]|new[13]	_	_
3-25	158-159	,	_	_	_	_
3-26	160-163	and	_	_	_	_
3-27	164-169	could	_	_	_	_
3-28	170-174	also	_	_	_	_
3-29	175-179	form	abstract	new	coref|none	15-26[112_0]|3-29[0_112]
3-30	180-191	potentially	substance[14]	new[14]	coref	8-14[54_14]
3-31	192-197	toxic	substance[14]	new[14]	_	_
3-32	198-207	compounds	substance[14]	new[14]	_	_
3-33	208-209	.	_	_	_	_

#Text=The use of synthetic antioxidants , such as butylated hydroxytoluene , butylated hydroxyanisole , or n-propyl gallate to delay lipid oxidation is currently questioned due to their possible harmful effects on human health , and the use of natural antioxidants is of growing interest .
4-1	210-213	The	abstract[15]	new[15]	_	_
4-2	214-217	use	abstract[15]	new[15]	_	_
4-3	218-220	of	abstract[15]	new[15]	_	_
4-4	221-230	synthetic	abstract[15]|substance[16]	new[15]|new[16]	ana	4-27[0_16]
4-5	231-243	antioxidants	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-6	244-245	,	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-7	246-250	such	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-8	251-253	as	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-9	254-263	butylated	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-10	264-278	hydroxytoluene	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-11	279-280	,	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-12	281-290	butylated	abstract[15]|substance[16]|substance[17]	new[15]|new[16]|new[17]	_	_
4-13	291-305	hydroxyanisole	abstract[15]|substance[16]|substance[17]	new[15]|new[16]|new[17]	_	_
4-14	306-307	,	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-15	308-310	or	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-16	311-319	n-propyl	abstract[15]|substance[16]|substance[18]	new[15]|new[16]|new[18]	_	_
4-17	320-327	gallate	abstract[15]|substance[16]|substance[18]	new[15]|new[16]|new[18]	_	_
4-18	328-330	to	_	_	_	_
4-19	331-336	delay	_	_	_	_
4-20	337-342	lipid	person|event[20]	giv|giv[20]	coref|coref|coref|coref	6-9|6-9[34_20]|6-9|6-9[34_20]
4-21	343-352	oxidation	event[20]	giv[20]	_	_
4-22	353-355	is	_	_	_	_
4-23	356-365	currently	_	_	_	_
4-24	366-376	questioned	_	_	_	_
4-25	377-380	due	_	_	_	_
4-26	381-383	to	_	_	_	_
4-27	384-389	their	substance|abstract[22]	giv|new[22]	coref|coref	4-39[25_0]|4-39[25_0]
4-28	390-398	possible	abstract[22]	new[22]	_	_
4-29	399-406	harmful	abstract[22]	new[22]	_	_
4-30	407-414	effects	abstract[22]	new[22]	_	_
4-31	415-417	on	abstract[22]	new[22]	_	_
4-32	418-423	human	abstract[22]|abstract[23]	new[22]|new[23]	_	_
4-33	424-430	health	abstract[22]|abstract[23]	new[22]|new[23]	_	_
4-34	431-432	,	_	_	_	_
4-35	433-436	and	_	_	_	_
4-36	437-440	the	abstract[24]	new[24]	coref	4-43[26_24]
4-37	441-444	use	abstract[24]	new[24]	_	_
4-38	445-447	of	abstract[24]	new[24]	_	_
4-39	448-455	natural	abstract[24]|substance[25]	new[24]|giv[25]	_	_
4-40	456-468	antioxidants	abstract[24]|substance[25]	new[24]|giv[25]	_	_
4-41	469-471	is	_	_	_	_
4-42	472-474	of	_	_	_	_
4-43	475-482	growing	abstract[26]	giv[26]	_	_
4-44	483-491	interest	abstract[26]	giv[26]	_	_
4-45	492-493	.	_	_	_	_

#Text=In recent years , flavonoids have been used to improve the oxidative stability of foods .
5-1	494-496	In	_	_	_	_
5-2	497-503	recent	time[27]	new[27]	_	_
5-3	504-509	years	time[27]	new[27]	_	_
5-4	510-511	,	_	_	_	_
5-5	512-522	flavonoids	substance	new	coref	6-6
5-6	523-527	have	_	_	_	_
5-7	528-532	been	_	_	_	_
5-8	533-537	used	_	_	_	_
5-9	538-540	to	_	_	_	_
5-10	541-548	improve	_	_	_	_
5-11	549-552	the	abstract[29]	new[29]	coref	7-37[48_29]
5-12	553-562	oxidative	abstract[29]	new[29]	_	_
5-13	563-572	stability	abstract[29]	new[29]	_	_
5-14	573-575	of	abstract[29]	new[29]	_	_
5-15	576-581	foods	abstract[29]|substance	new[29]|new	_	_
5-16	582-583	.	_	_	_	_

#Text=The main mechanisms by which flavonoids act against lipid oxidation involve transferring a hydrogen atom or electrons to a peroxyl radical and metal chelation .
6-1	584-587	The	abstract[31]	new[31]	_	_
6-2	588-592	main	abstract[31]	new[31]	_	_
6-3	593-603	mechanisms	abstract[31]	new[31]	_	_
6-4	604-606	by	_	_	_	_
6-5	607-612	which	_	_	_	_
6-6	613-623	flavonoids	substance	giv	coref	7-1[40_0]
6-7	624-627	act	_	_	_	_
6-8	628-635	against	_	_	_	_
6-9	636-641	lipid	person|event[34]	giv|giv[34]	coref|coref	7-27|7-27
6-10	642-651	oxidation	event[34]	giv[34]	_	_
6-11	652-659	involve	_	_	_	_
6-12	660-672	transferring	_	_	_	_
6-13	673-674	a	substance[35]	new[35]	_	_
6-14	675-683	hydrogen	substance[35]	new[35]	_	_
6-15	684-688	atom	substance[35]	new[35]	_	_
6-16	689-691	or	_	_	_	_
6-17	692-701	electrons	substance[36]	new[36]	_	_
6-18	702-704	to	substance[36]	new[36]	_	_
6-19	705-706	a	substance[36]|substance[39]	new[36]|new[39]	_	_
6-20	707-714	peroxyl	substance[36]|abstract|substance[39]	new[36]|new|new[39]	_	_
6-21	715-722	radical	substance[36]|substance[39]	new[36]|new[39]	_	_
6-22	723-726	and	substance[36]|substance[39]	new[36]|new[39]	_	_
6-23	727-732	metal	substance[36]|substance|substance[39]	new[36]|new|new[39]	_	_
6-24	733-742	chelation	substance[36]|substance[39]	new[36]|new[39]	_	_
6-25	743-744	.	_	_	_	_

#Text=Free flavonoids , mainly quercetin , myricetin , morin , ( +)catechin , ( −)epigallocatechin , ( −)epicatechin , and kaempferol have been incorporated in different lipid systems with varying degrees of success in terms of oxidative stability .
7-1	745-749	Free	substance[40]	giv[40]	appos	7-4[41_40]
7-2	750-760	flavonoids	substance[40]	giv[40]	_	_
7-3	761-762	,	_	_	_	_
7-4	763-769	mainly	substance[41]	giv[41]	coref	8-4[50_41]
7-5	770-779	quercetin	substance[41]	giv[41]	_	_
7-6	780-781	,	substance[41]	giv[41]	_	_
7-7	782-791	myricetin	substance[41]	giv[41]	_	_
7-8	792-793	,	substance[41]	giv[41]	_	_
7-9	794-799	morin	substance[41]	giv[41]	_	_
7-10	800-801	,	_	_	_	_
7-11	802-803	(	_	_	_	_
7-12	804-814	+)catechin	abstract	new	_	_
7-13	815-816	,	_	_	_	_
7-14	817-818	(	_	_	_	_
7-15	819-837	−)epigallocatechin	_	_	_	_
7-16	838-839	,	_	_	_	_
7-17	840-841	(	_	_	_	_
7-18	842-855	−)epicatechin	_	_	_	_
7-19	856-857	,	_	_	_	_
7-20	858-861	and	_	_	_	_
7-21	862-872	kaempferol	_	_	_	_
7-22	873-877	have	_	_	_	_
7-23	878-882	been	_	_	_	_
7-24	883-895	incorporated	_	_	_	_
7-25	896-898	in	_	_	_	_
7-26	899-908	different	object[44]	new[44]	coref	8-7[52_44]
7-27	909-914	lipid	organization|object[44]	giv|new[44]	coref	8-7
7-28	915-922	systems	object[44]	new[44]	_	_
7-29	923-927	with	object[44]	new[44]	_	_
7-30	928-935	varying	object[44]|abstract[45]	new[44]|new[45]	_	_
7-31	936-943	degrees	object[44]|abstract[45]	new[44]|new[45]	_	_
7-32	944-946	of	object[44]|abstract[45]	new[44]|new[45]	_	_
7-33	947-954	success	object[44]|abstract[45]|abstract	new[44]|new[45]|new	_	_
7-34	955-957	in	object[44]|abstract[45]	new[44]|new[45]	_	_
7-35	958-963	terms	object[44]|abstract[45]	new[44]|new[45]	_	_
7-36	964-966	of	object[44]|abstract[45]	new[44]|new[45]	_	_
7-37	967-976	oxidative	object[44]|abstract[45]|abstract|abstract[48]	new[44]|new[45]|new|giv[48]	coref|coref	8-21[0_48]|8-21[0_48]
7-38	977-986	stability	object[44]|abstract[45]|abstract[48]	new[44]|new[45]|giv[48]	_	_
7-39	987-988	.	_	_	_	_

#Text=The incorporation of free flavonoids in lipid systems may have some drawbacks since these phenolic compounds have limited solubility and stability , together with unpleasant flavors in some cases .
8-1	989-992	The	abstract[49]	new[49]	_	_
8-2	993-1006	incorporation	abstract[49]	new[49]	_	_
8-3	1007-1009	of	abstract[49]	new[49]	_	_
8-4	1010-1014	free	abstract[49]|substance[50]	new[49]|giv[50]	coref	9-3[0_50]
8-5	1015-1025	flavonoids	abstract[49]|substance[50]	new[49]|giv[50]	_	_
8-6	1026-1028	in	abstract[49]|substance[50]	new[49]|giv[50]	_	_
8-7	1029-1034	lipid	abstract[49]|substance[50]|organization|object[52]	new[49]|giv[50]|giv|giv[52]	coref|coref|coref|coref	13-22|13-22[98_52]|13-22|13-22[98_52]
8-8	1035-1042	systems	abstract[49]|substance[50]|object[52]	new[49]|giv[50]|giv[52]	_	_
8-9	1043-1046	may	_	_	_	_
8-10	1047-1051	have	_	_	_	_
8-11	1052-1056	some	abstract[53]	new[53]	_	_
8-12	1057-1066	drawbacks	abstract[53]	new[53]	_	_
8-13	1067-1072	since	_	_	_	_
8-14	1073-1078	these	substance[54]	giv[54]	coref	10-16[68_54]
8-15	1079-1087	phenolic	substance[54]	giv[54]	_	_
8-16	1088-1097	compounds	substance[54]	giv[54]	_	_
8-17	1098-1102	have	_	_	_	_
8-18	1103-1110	limited	substance[55]	new[55]	_	_
8-19	1111-1121	solubility	substance[55]	new[55]	_	_
8-20	1122-1125	and	_	_	_	_
8-21	1126-1135	stability	abstract	giv	_	_
8-22	1136-1137	,	_	_	_	_
8-23	1138-1146	together	abstract[57]	giv[57]	_	_
8-24	1147-1151	with	abstract[57]	giv[57]	_	_
8-25	1152-1162	unpleasant	abstract[57]	giv[57]	_	_
8-26	1163-1170	flavors	abstract[57]	giv[57]	_	_
8-27	1171-1173	in	abstract[57]	giv[57]	_	_
8-28	1174-1178	some	abstract[57]|abstract[58]	giv[57]|new[58]	_	_
8-29	1179-1184	cases	abstract[57]|abstract[58]	giv[57]|new[58]	_	_
8-30	1185-1186	.	_	_	_	_

#Text=Encapsulation of flavonoids is a technology which could enhance the stability of flavonoids .
9-1	1187-1200	Encapsulation	abstract[59]	new[59]	coref	9-5[61_59]
9-2	1201-1203	of	abstract[59]	new[59]	_	_
9-3	1204-1214	flavonoids	abstract[59]|substance	new[59]|giv	coref	9-13
9-4	1215-1217	is	_	_	_	_
9-5	1218-1219	a	abstract[61]	giv[61]	coref	10-3[0_61]
9-6	1220-1230	technology	abstract[61]	giv[61]	_	_
9-7	1231-1236	which	_	_	_	_
9-8	1237-1242	could	_	_	_	_
9-9	1243-1250	enhance	_	_	_	_
9-10	1251-1254	the	abstract[62]	new[62]	_	_
9-11	1255-1264	stability	abstract[62]	new[62]	_	_
9-12	1265-1267	of	abstract[62]	new[62]	_	_
9-13	1268-1278	flavonoids	abstract[62]|substance	new[62]|giv	coref	13-15[95_0]
9-14	1279-1280	.	_	_	_	_

#Text=Among the encapsulation methods , spray-drying is the most widely used for the encapsulation of bioactive compounds in the food industry .
10-1	1281-1286	Among	_	_	_	_
10-2	1287-1290	the	abstract[65]	new[65]	_	_
10-3	1291-1304	encapsulation	abstract|abstract[65]	giv|new[65]	_	_
10-4	1305-1312	methods	abstract[65]	new[65]	_	_
10-5	1313-1314	,	_	_	_	_
10-6	1315-1327	spray-drying	substance	new	coref	16-7
10-7	1328-1330	is	_	_	_	_
10-8	1331-1334	the	_	_	_	_
10-9	1335-1339	most	_	_	_	_
10-10	1340-1346	widely	_	_	_	_
10-11	1347-1351	used	_	_	_	_
10-12	1352-1355	for	_	_	_	_
10-13	1356-1359	the	abstract[67]	new[67]	_	_
10-14	1360-1373	encapsulation	abstract[67]	new[67]	_	_
10-15	1374-1376	of	abstract[67]	new[67]	_	_
10-16	1377-1386	bioactive	abstract[67]|substance[68]	new[67]|giv[68]	_	_
10-17	1387-1396	compounds	abstract[67]|substance[68]	new[67]|giv[68]	_	_
10-18	1397-1399	in	abstract[67]|substance[68]	new[67]|giv[68]	_	_
10-19	1400-1403	the	abstract[67]|substance[68]|abstract[70]	new[67]|giv[68]|new[70]	_	_
10-20	1404-1408	food	abstract[67]|substance[68]|substance|abstract[70]	new[67]|giv[68]|giv|new[70]	_	_
10-21	1409-1417	industry	abstract[67]|substance[68]|abstract[70]	new[67]|giv[68]|new[70]	_	_
10-22	1418-1419	.	_	_	_	_

#Text=Inulin is a linear fructo-oligosaccharide composed of fructosyl units ( β ( 2→1 ) linkage ) and usually contains one terminal glucose moiety per molecule . β-linkage makes inulin resistant to hydrolysis by human gastrointestinal enzymes and it is classified as colonic delivery biopolymer .
11-1	1420-1426	Inulin	substance	new	coref	11-3[72_0]
11-2	1427-1429	is	_	_	_	_
11-3	1430-1431	a	substance[72]	giv[72]	coref	11-29[0_72]
11-4	1432-1438	linear	substance[72]	giv[72]	_	_
11-5	1439-1461	fructo-oligosaccharide	substance[72]	giv[72]	_	_
11-6	1462-1470	composed	_	_	_	_
11-7	1471-1473	of	_	_	_	_
11-8	1474-1483	fructosyl	organization[73]	new[73]	_	_
11-9	1484-1489	units	organization[73]	new[73]	_	_
11-10	1490-1491	(	_	_	_	_
11-11	1492-1493	β	quantity[74]	new[74]	_	_
11-12	1494-1495	(	quantity[74]	new[74]	_	_
11-13	1496-1499	2→1	quantity[74]	new[74]	_	_
11-14	1500-1501	)	quantity[74]	new[74]	_	_
11-15	1502-1509	linkage	object	new	_	_
11-16	1510-1511	)	_	_	_	_
11-17	1512-1515	and	_	_	_	_
11-18	1516-1523	usually	_	_	_	_
11-19	1524-1532	contains	_	_	_	_
11-20	1533-1536	one	substance[77]	new[77]	_	_
11-21	1537-1545	terminal	substance[77]	new[77]	_	_
11-22	1546-1553	glucose	substance|substance[77]	new|new[77]	_	_
11-23	1554-1560	moiety	substance[77]	new[77]	_	_
11-24	1561-1564	per	substance[77]	new[77]	_	_
11-25	1565-1573	molecule	substance[77]|abstract	new[77]|new	ana	11-38
11-26	1574-1575	.	_	_	_	_
11-27	1576-1585	β-linkage	substance	new	_	_
11-28	1586-1591	makes	_	_	_	_
11-29	1592-1598	inulin	substance	giv	coref	12-2
11-30	1599-1608	resistant	_	_	_	_
11-31	1609-1611	to	_	_	_	_
11-32	1612-1622	hydrolysis	substance[81]	new[81]	_	_
11-33	1623-1625	by	substance[81]	new[81]	_	_
11-34	1626-1631	human	substance[81]|object[82]	new[81]|new[82]	_	_
11-35	1632-1648	gastrointestinal	substance[81]|object[82]	new[81]|new[82]	_	_
11-36	1649-1656	enzymes	substance[81]|object[82]	new[81]|new[82]	_	_
11-37	1657-1660	and	_	_	_	_
11-38	1661-1663	it	abstract	giv	ana	12-8
11-39	1664-1666	is	_	_	_	_
11-40	1667-1677	classified	_	_	_	_
11-41	1678-1680	as	_	_	_	_
11-42	1681-1688	colonic	_	_	_	_
11-43	1689-1697	delivery	abstract	new	_	_
11-44	1698-1708	biopolymer	_	_	_	_
11-45	1709-1710	.	_	_	_	_

#Text=Although inulin is moderately water soluble , it is used as an encapsulating agent by spray drying due to low viscosity and colorless solutions .
12-1	1711-1719	Although	_	_	_	_
12-2	1720-1726	inulin	person	giv	coref	12-4[87_0]
12-3	1727-1729	is	_	_	_	_
12-4	1730-1740	moderately	person[87]	giv[87]	coref	14-14[0_87]
12-5	1741-1746	water	substance|person[87]	new|giv[87]	_	_
12-6	1747-1754	soluble	person[87]	giv[87]	_	_
12-7	1755-1756	,	_	_	_	_
12-8	1757-1759	it	abstract	giv	_	_
12-9	1760-1762	is	_	_	_	_
12-10	1763-1767	used	_	_	_	_
12-11	1768-1770	as	_	_	_	_
12-12	1771-1773	an	_	_	_	_
12-13	1774-1787	encapsulating	_	_	_	_
12-14	1788-1793	agent	_	_	_	_
12-15	1794-1796	by	_	_	_	_
12-16	1797-1802	spray	object	new	_	_
12-17	1803-1809	drying	_	_	_	_
12-18	1810-1813	due	_	_	_	_
12-19	1814-1816	to	_	_	_	_
12-20	1817-1820	low	substance[90]	new[90]	_	_
12-21	1821-1830	viscosity	substance[90]	new[90]	_	_
12-22	1831-1834	and	_	_	_	_
12-23	1835-1844	colorless	substance[91]	new[91]	_	_
12-24	1845-1854	solutions	substance[91]	new[91]	_	_
12-25	1855-1856	.	_	_	_	_

#Text=However , there are few studies focused on the effect of the incorporation of microencapsulated flavonoids on the oxidative stability of lipid systems .
13-1	1857-1864	However	_	_	_	_
13-2	1865-1866	,	_	_	_	_
13-3	1867-1872	there	_	_	_	_
13-4	1873-1876	are	_	_	_	_
13-5	1877-1880	few	event[92]	new[92]	coref	14-2[99_92]
13-6	1881-1888	studies	event[92]	new[92]	_	_
13-7	1889-1896	focused	_	_	_	_
13-8	1897-1899	on	_	_	_	_
13-9	1900-1903	the	abstract[93]	new[93]	_	_
13-10	1904-1910	effect	abstract[93]	new[93]	_	_
13-11	1911-1913	of	abstract[93]	new[93]	_	_
13-12	1914-1917	the	abstract[93]|abstract[94]	new[93]|new[94]	_	_
13-13	1918-1931	incorporation	abstract[93]|abstract[94]	new[93]|new[94]	_	_
13-14	1932-1934	of	abstract[93]|abstract[94]	new[93]|new[94]	_	_
13-15	1935-1952	microencapsulated	abstract[93]|abstract[94]|substance[95]	new[93]|new[94]|giv[95]	coref	14-10[0_95]
13-16	1953-1963	flavonoids	abstract[93]|abstract[94]|substance[95]	new[93]|new[94]|giv[95]	_	_
13-17	1964-1966	on	abstract[93]|abstract[94]|substance[95]	new[93]|new[94]|giv[95]	_	_
13-18	1967-1970	the	abstract[93]|abstract[94]|substance[95]|abstract[96]	new[93]|new[94]|giv[95]|new[96]	coref	19-38[153_96]
13-19	1971-1980	oxidative	abstract[93]|abstract[94]|substance[95]|abstract[96]	new[93]|new[94]|giv[95]|new[96]	_	_
13-20	1981-1990	stability	abstract[93]|abstract[94]|substance[95]|abstract[96]	new[93]|new[94]|giv[95]|new[96]	_	_
13-21	1991-1993	of	abstract[93]|abstract[94]|substance[95]|abstract[96]	new[93]|new[94]|giv[95]|new[96]	_	_
13-22	1994-1999	lipid	abstract[93]|abstract[94]|substance[95]|abstract[96]|organization|object[98]	new[93]|new[94]|giv[95]|new[96]|giv|giv[98]	coref|coref|coref|coref	18-9|19-42[154_98]|18-9|19-42[154_98]
13-23	2000-2007	systems	abstract[93]|abstract[94]|substance[95]|abstract[96]|object[98]	new[93]|new[94]|giv[95]|new[96]|giv[98]	_	_
13-24	2008-2009	.	_	_	_	_

#Text=In previous studies undertaken by our research group , flavonoids were microencapsulated with inulin ( lipid-insoluble polymer ) , where channelizing agents ( lipid-soluble polymer ) were incorporated .
14-1	2010-2012	In	_	_	_	_
14-2	2013-2021	previous	event[99]	giv[99]	_	_
14-3	2022-2029	studies	event[99]	giv[99]	_	_
14-4	2030-2040	undertaken	_	_	_	_
14-5	2041-2043	by	_	_	_	_
14-6	2044-2047	our	person|organization[101]	acc|new[101]	_	_
14-7	2048-2056	research	organization[101]	new[101]	_	_
14-8	2057-2062	group	organization[101]	new[101]	_	_
14-9	2063-2064	,	_	_	_	_
14-10	2065-2075	flavonoids	substance	giv	coref	15-7[108_0]
14-11	2076-2080	were	_	_	_	_
14-12	2081-2098	microencapsulated	_	_	_	_
14-13	2099-2103	with	_	_	_	_
14-14	2104-2110	inulin	substance	giv	appos	14-16[104_0]
14-15	2111-2112	(	_	_	_	_
14-16	2113-2128	lipid-insoluble	substance[104]	giv[104]	appos	14-24[106_104]
14-17	2129-2136	polymer	substance[104]	giv[104]	_	_
14-18	2137-2138	)	_	_	_	_
14-19	2139-2140	,	_	_	_	_
14-20	2141-2146	where	_	_	_	_
14-21	2147-2159	channelizing	_	_	_	_
14-22	2160-2166	agents	person	new	_	_
14-23	2167-2168	(	_	_	_	_
14-24	2169-2182	lipid-soluble	substance[106]	giv[106]	coref	17-7[0_106]
14-25	2183-2190	polymer	substance[106]	giv[106]	_	_
14-26	2191-2192	)	_	_	_	_
14-27	2193-2197	were	_	_	_	_
14-28	2198-2210	incorporated	_	_	_	_
14-29	2211-2212	.	_	_	_	_

#Text=These microparticles were able to release the encapsulated flavonoids and improve the oxidative stability of methyl linoleate and vegetable oils , which was attributed to the formation of channels inside the microparticles , favoring the diffusion of flavonoids .
15-1	2213-2218	These	object[107]	new[107]	coref	15-31[114_107]
15-2	2219-2233	microparticles	object[107]	new[107]	_	_
15-3	2234-2238	were	_	_	_	_
15-4	2239-2243	able	_	_	_	_
15-5	2244-2246	to	_	_	_	_
15-6	2247-2254	release	_	_	_	_
15-7	2255-2258	the	substance[108]	giv[108]	coref	15-38[0_108]
15-8	2259-2271	encapsulated	substance[108]	giv[108]	_	_
15-9	2272-2282	flavonoids	substance[108]	giv[108]	_	_
15-10	2283-2286	and	_	_	_	_
15-11	2287-2294	improve	_	_	_	_
15-12	2295-2298	the	abstract[109]	new[109]	_	_
15-13	2299-2308	oxidative	abstract[109]	new[109]	_	_
15-14	2309-2318	stability	abstract[109]	new[109]	_	_
15-15	2319-2321	of	abstract[109]	new[109]	_	_
15-16	2322-2328	methyl	abstract[109]|substance[110]	new[109]|new[110]	_	_
15-17	2329-2338	linoleate	abstract[109]|substance[110]	new[109]|new[110]	_	_
15-18	2339-2342	and	abstract[109]	new[109]	_	_
15-19	2343-2352	vegetable	abstract[109]|substance[111]	new[109]|new[111]	_	_
15-20	2353-2357	oils	abstract[109]|substance[111]	new[109]|new[111]	_	_
15-21	2358-2359	,	_	_	_	_
15-22	2360-2365	which	_	_	_	_
15-23	2366-2369	was	_	_	_	_
15-24	2370-2380	attributed	_	_	_	_
15-25	2381-2383	to	_	_	_	_
15-26	2384-2387	the	abstract[112]	new[112]	_	_
15-27	2388-2397	formation	abstract[112]	new[112]	_	_
15-28	2398-2400	of	abstract[112]	new[112]	_	_
15-29	2401-2409	channels	abstract[112]|object[113]	new[112]|new[113]	_	_
15-30	2410-2416	inside	abstract[112]|object[113]	new[112]|new[113]	_	_
15-31	2417-2420	the	abstract[112]|object[113]|object[114]	new[112]|new[113]|giv[114]	coref	17-35[132_114]
15-32	2421-2435	microparticles	abstract[112]|object[113]|object[114]	new[112]|new[113]|giv[114]	_	_
15-33	2436-2437	,	_	_	_	_
15-34	2438-2446	favoring	_	_	_	_
15-35	2447-2450	the	abstract[115]	new[115]	_	_
15-36	2451-2460	diffusion	abstract[115]	new[115]	_	_
15-37	2461-2463	of	abstract[115]	new[115]	_	_
15-38	2464-2474	flavonoids	abstract[115]|substance	new[115]|giv	coref	19-9
15-39	2475-2476	.	_	_	_	_

#Text=In general , powders obtained by spray-drying are amorphous .
16-1	2477-2479	In	_	_	_	_
16-2	2480-2487	general	person	new	_	_
16-3	2488-2489	,	_	_	_	_
16-4	2490-2497	powders	object	new	_	_
16-5	2498-2506	obtained	_	_	_	_
16-6	2507-2509	by	_	_	_	_
16-7	2510-2522	spray-drying	abstract	giv	coref	17-12[124_0]
16-8	2523-2526	are	_	_	_	_
16-9	2527-2536	amorphous	_	_	_	_
16-10	2537-2538	.	_	_	_	_

#Text=However , in the case of inulin , process variables of spray-drying such as feed temperature and inlet air temperature have been reported to influence both the morphology and the degree of crystallinity of the microparticles .
17-1	2539-2546	However	_	_	_	_
17-2	2547-2548	,	_	_	_	_
17-3	2549-2551	in	_	_	_	_
17-4	2552-2555	the	substance[120]	new[120]	_	_
17-5	2556-2560	case	substance[120]	new[120]	_	_
17-6	2561-2563	of	substance[120]	new[120]	_	_
17-7	2564-2570	inulin	substance[120]|substance	new[120]|giv	coref	19-17
17-8	2571-2572	,	_	_	_	_
17-9	2573-2580	process	abstract|abstract[123]	new|new[123]	_	_
17-10	2581-2590	variables	abstract[123]	new[123]	_	_
17-11	2591-2593	of	_	_	_	_
17-12	2594-2606	spray-drying	substance[124]	giv[124]	_	_
17-13	2607-2611	such	substance[124]	giv[124]	_	_
17-14	2612-2614	as	substance[124]	giv[124]	_	_
17-15	2615-2619	feed	substance[124]|substance|abstract[126]	giv[124]|new|new[126]	_	_
17-16	2620-2631	temperature	substance[124]|abstract[126]	giv[124]|new[126]	_	_
17-17	2632-2635	and	substance[124]	giv[124]	_	_
17-18	2636-2641	inlet	substance[124]|abstract[128]	giv[124]|new[128]	_	_
17-19	2642-2645	air	substance[124]|abstract|abstract[128]	giv[124]|new|new[128]	_	_
17-20	2646-2657	temperature	substance[124]|abstract[128]	giv[124]|new[128]	_	_
17-21	2658-2662	have	_	_	_	_
17-22	2663-2667	been	_	_	_	_
17-23	2668-2676	reported	_	_	_	_
17-24	2677-2679	to	_	_	_	_
17-25	2680-2689	influence	abstract	new	none|none	17-25[0_149]|18-22
17-26	2690-2694	both	person[129]	new[129]	_	_
17-27	2695-2698	the	person[129]	new[129]	_	_
17-28	2699-2709	morphology	person[129]	new[129]	_	_
17-29	2710-2713	and	_	_	_	_
17-30	2714-2717	the	abstract[130]	new[130]	_	_
17-31	2718-2724	degree	abstract[130]	new[130]	_	_
17-32	2725-2727	of	abstract[130]	new[130]	_	_
17-33	2728-2741	crystallinity	abstract[130]|substance[131]	new[130]|new[131]	_	_
17-34	2742-2744	of	abstract[130]|substance[131]	new[130]|new[131]	_	_
17-35	2745-2748	the	abstract[130]|substance[131]|object[132]	new[130]|new[131]|giv[132]	coref	18-2[133_132]
17-36	2749-2763	microparticles	abstract[130]|substance[131]|object[132]	new[130]|new[131]|giv[132]	_	_
17-37	2764-2765	.	_	_	_	_

#Text=When the flavonoid-inulin microparticles are incorporated into a lipid system , the physical state of these microparticles ( semi-crystalline/amorphous ) may influence the oxidative stability of the system , but this still has not been addressed .
18-1	2766-2770	When	_	_	_	_
18-2	2771-2774	the	object[133]	giv[133]	coref	18-16[137_133]
18-3	2775-2791	flavonoid-inulin	object[133]	giv[133]	_	_
18-4	2792-2806	microparticles	object[133]	giv[133]	_	_
18-5	2807-2810	are	_	_	_	_
18-6	2811-2823	incorporated	_	_	_	_
18-7	2824-2828	into	_	_	_	_
18-8	2829-2830	a	abstract[135]	new[135]	coref	18-27[140_135]
18-9	2831-2836	lipid	organization|abstract[135]	giv|new[135]	_	_
18-10	2837-2843	system	abstract[135]	new[135]	_	_
18-11	2844-2845	,	_	_	_	_
18-12	2846-2849	the	abstract[136]	new[136]	_	_
18-13	2850-2858	physical	abstract[136]	new[136]	_	_
18-14	2859-2864	state	abstract[136]	new[136]	_	_
18-15	2865-2867	of	abstract[136]	new[136]	_	_
18-16	2868-2873	these	abstract[136]|object[137]	new[136]|giv[137]	coref	19-15[146_137]
18-17	2874-2888	microparticles	abstract[136]|object[137]	new[136]|giv[137]	_	_
18-18	2889-2890	(	_	_	_	_
18-19	2891-2917	semi-crystalline/amorphous	person	new	_	_
18-20	2918-2919	)	_	_	_	_
18-21	2920-2923	may	_	_	_	_
18-22	2924-2933	influence	abstract	new	coref	19-24[149_0]
18-23	2934-2937	the	abstract[139]	new[139]	_	_
18-24	2938-2947	oxidative	abstract[139]	new[139]	_	_
18-25	2948-2957	stability	abstract[139]	new[139]	_	_
18-26	2958-2960	of	abstract[139]	new[139]	_	_
18-27	2961-2964	the	abstract[139]|abstract[140]	new[139]|giv[140]	ana	18-31[0_140]
18-28	2965-2971	system	abstract[139]|abstract[140]	new[139]|giv[140]	_	_
18-29	2972-2973	,	_	_	_	_
18-30	2974-2977	but	_	_	_	_
18-31	2978-2982	this	abstract	giv	_	_
18-32	2983-2988	still	_	_	_	_
18-33	2989-2992	has	_	_	_	_
18-34	2993-2996	not	_	_	_	_
18-35	2997-3001	been	_	_	_	_
18-36	3002-3011	addressed	_	_	_	_
18-37	3012-3013	.	_	_	_	_

#Text=The objective of this research was to design flavonoids ( epicatechin and quercetin ) microparticles with inulin as encapsulating agent and to evaluate the influence of the physical state of spray-dried flavonoid microparticles ( semi-crystalline/amorphous ) on the oxidative stability of lipid systems .
19-1	3014-3017	The	abstract[142]	new[142]	_	_
19-2	3018-3027	objective	abstract[142]	new[142]	_	_
19-3	3028-3030	of	abstract[142]	new[142]	_	_
19-4	3031-3035	this	abstract[142]|abstract[143]	new[142]|new[143]	_	_
19-5	3036-3044	research	abstract[142]|abstract[143]	new[142]|new[143]	_	_
19-6	3045-3048	was	_	_	_	_
19-7	3049-3051	to	_	_	_	_
19-8	3052-3058	design	_	_	_	_
19-9	3059-3069	flavonoids	substance	giv	appos	19-11[145_0]
19-10	3070-3071	(	_	_	_	_
19-11	3072-3083	epicatechin	substance[145]	giv[145]	_	_
19-12	3084-3087	and	substance[145]	giv[145]	_	_
19-13	3088-3097	quercetin	substance[145]	giv[145]	_	_
19-14	3098-3099	)	_	_	_	_
19-15	3100-3114	microparticles	object[146]	giv[146]	coref	19-31[152_146]
19-16	3115-3119	with	object[146]	giv[146]	_	_
19-17	3120-3126	inulin	object[146]|substance	giv[146]|giv	_	_
19-18	3127-3129	as	_	_	_	_
19-19	3130-3143	encapsulating	_	_	_	_
19-20	3144-3149	agent	person	new	_	_
19-21	3150-3153	and	_	_	_	_
19-22	3154-3156	to	_	_	_	_
19-23	3157-3165	evaluate	_	_	_	_
19-24	3166-3169	the	abstract[149]	new[149]	_	_
19-25	3170-3179	influence	abstract[149]	new[149]	_	_
19-26	3180-3182	of	abstract[149]	new[149]	_	_
19-27	3183-3186	the	abstract[149]|abstract[150]	new[149]|new[150]	_	_
19-28	3187-3195	physical	abstract[149]|abstract[150]	new[149]|new[150]	_	_
19-29	3196-3201	state	abstract[149]|abstract[150]	new[149]|new[150]	_	_
19-30	3202-3204	of	abstract[149]|abstract[150]	new[149]|new[150]	_	_
19-31	3205-3216	spray-dried	abstract[149]|abstract[150]|object[152]	new[149]|new[150]|giv[152]	_	_
19-32	3217-3226	flavonoid	abstract[149]|abstract[150]|object|object[152]	new[149]|new[150]|new|giv[152]	_	_
19-33	3227-3241	microparticles	abstract[149]|abstract[150]|object[152]	new[149]|new[150]|giv[152]	_	_
19-34	3242-3243	(	_	_	_	_
19-35	3244-3270	semi-crystalline/amorphous	_	_	_	_
19-36	3271-3272	)	_	_	_	_
19-37	3273-3275	on	_	_	_	_
19-38	3276-3279	the	abstract[153]	giv[153]	_	_
19-39	3280-3289	oxidative	abstract[153]	giv[153]	_	_
19-40	3290-3299	stability	abstract[153]	giv[153]	_	_
19-41	3300-3302	of	abstract[153]	giv[153]	_	_
19-42	3303-3308	lipid	abstract[153]|object[154]	giv[153]|giv[154]	_	_
19-43	3309-3316	systems	abstract[153]|object[154]	giv[153]|giv[154]	_	_
19-44	3317-3318	.	_	_	_	_
